Six years of clinical experience with the TEKNA® bileaflet heart valve;Sechs jahre klinische erfahrung mit TEKNA® doppelflugel- herzklappenprothese

Zeitschrift fur Kardiologie

Volumn 89, Issue 5, 2000, Pages 408-417

  Hoda, M R ^a   Laufer, G ^a   Moidl, R ^a   Simon, P ^a   Eigenbauer, E ^a   Moritz, A ^b   Wolner, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Heart valve disease; Mechanical heart valves; TEKNA prosthesis; Valve replacement

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BLEEDING; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; QUALITY OF LIFE; REOPERATION; SURVIVAL RATE; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

EID: 0034130872     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050506     Document Type: Article

References (28)

1. Altmann R, Rouvier J, Gurfinkel E, Dòrtenico O, Manzanel R, La Funte L de, Favarolo RG (1991) Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 101:427-431
2. Akins CW (1995) Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 60:1836-1844
3. Antunes MJ (1991) Mechanical failure of a St. Jude Medical Prosthesis. Am J Cardiol 68:841-842
4. Bernal MJ, Rabasa JM,Gutierrez-Garcia F, Morales C, Nistal JF, Revuelta JM (1998) The CarboMedics valve: Experience with 1049 implants. Ann Thorac Surg 65:137-143
5. Burke AP, Farb A, Sessums L, Virmani R (1994) Causes of sudden cardiac death in patients with replacement valves: An autopsy study. J Heart Valve Dis 3:10-16
6. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, Breckenridge IM (1988) Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation: Experience with 1004 Medtronic-Hall valves. Circulation 78 (suppl I):66-77
7. Butchart E (1991) Thrombosis, Embolism, and Bleeding. In: Bodnar E, Frater R. Replacement cardiac valves. Pergamon Press, pp 77-98
8. Cary NC (1985). The lifetable procedure. In: SAS users guide statistics, version 5. SAS Institute, pp 529-557
9. Copeland JG (1995) An international experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 4:56-62
10. Czer LSC, Chaux A, Matloff JM, DeRobertis MA, Nessim SA, Scarlata D, Khan SS, Kass RM, Tsai TP, Blanche C, Gray RJ (1990) Ten-year experiience with the St. Jude Medical valve for primary valve replacement. J Thorac Cardiovasc Surg 100:44-55
11. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD (1996) Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 62:932-935
12. Fradet GJ, Jamieson WRE, Abel JG, Lichtenstein SV, Miyagishima RT, Ling H, Tyers GFO (1995) Clinical performance of biological and mechanical prostheses. Ann Thorac Surg 60:453-458
13. Giersiepen M, Wurzinge LJ, Opitz R, Reul H (1990) Estimation of shear stress related blood damage in heart valve prostheses: in vitro comparison of 25 aortic valves. Int J Artif Organs 13/5:300-306
14. Graf T, Fischer H, Reul H, Rau G (1991) Cavitation potential of mechanical heart valve prostheses. Int J Artif Organs 14:169-174
15. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S (1993) A comparison of outcoms in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 328:1289-1296
16. Horstkotte D, Schulte H, Bircks W, Strauer B (1993) Unexpected findings concerning tromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prosthesis. J Heart Valve Dis 2:291-301
17. Ibrahim M, O'Kane H, Cleland J, Gladstone D, Sarsam M, Patterson C (1994) The St. Jude Medical prosthesis. A thirteen-year experience. J Thorac Cardiovasc Surg 108:221-230
18. Klepetko W, Moritz A, Mlczoch J, Domanig E, Wolner E (1989) Leaflet fracture in Duromedics Edwards bileaflet valves. J Thorac Cardiovasc Surg 97:90-94
19. Kopf GS, Hammond GL, Geha AS, Elefteriades J, Hashim SW (1987) Long-term performance of the St. Jude Medical Valve: low incidence of thromboembolism and hemorrhagic complications with modest dosage of warfarin. Circulation 76 (suppl III):III-132
20. Moritz A, Klepetko W, Rödler S, Föger A, Schreiner W, Grabenwöger F, Wolner E (1993) Six-year follow-up after heart valve replacement with the Edwards Durmedics bilesflet prosthesis. Eur J Cardio-thorac Surg 7:84-90
21. Mykén PSU, Caidhal K, Larsson P, Larsson S, Wallentin I, Berggren HE (1995) Mechanical versus biological valve prosthesis: A ten-year comparison regarding function and quality of life. Ann Thorac Surg 60:447-452
22. Nitter-Hauge S, Abdelnoor M, Svennevig JL (1996) Fifteen-year experience with the Medtronic-Hall valve prosthesis. Circulation 94 (Suppl II): 105-108
23. Podesser BK, Khuenl-Brady G, Eigenbauer E, Rödler S, Schmiedberger A, Wolner E, Moritz A (1998) Long-term results of heart valve replacement with the Edwards Duromedics bileaflet prosthesis: A prospective ten-year clinical follow-up. J Thorac Cardiovasc Surg 115:1121-1129
24. Reul H, van Son JAM, Steinseifer U, Schmitz B, Schmidt A, Schmitz C, Rau G (1993) In vitro comparison of bileaflet aortic heart valve prostheses. J Thorac Cardiovasc Surg 106:412-420
25. Saour JN, Sieck JO, Rahim Mamo LA, Gallus AS (1990) Trial of differenl intensities of anticoagulants in patients with prosthetic heart valves. N Engl J Med 322:428-432
26. Scharf RE, Giers G (1998) Molekulare Mechanismen und Indikatoren der Thrombogenese nach Herzklappenersatz. Z Kardiol 87 (Suppl 4):7-19
27. Seybold-Epting W, Limet R, Scheld H, Frank G, Hannekum A, David M, Tatou E, Wolner E, Loisance D, Kassal H, Ryba EA (1998) Intermediate Follow Up of the Tekna Bileaflet Valve. J Heart Valve Dis 7:219-224
28. Stenzinger W (1998) Intensity of oral anticoagulant therapy after heart valve replacement Z Kardiol 87 (Suppl 4):37-41